MetLife (NYSE:MET) Posts Earnings Results, Beats Estimates By $0.13 EPS

MetLife (NYSE:MET) released its earnings results on Wednesday. The financial services provider reported $2.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.30 by $0.13, Zacks reports. MetLife had a return on equity of 23.23% and a net margin of 4.57%.The firm had revenue of $13.52 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter last year, the business posted $2.02 earnings per share. The firm’s revenue was up 10.5% on a year-over-year basis.

MetLife Price Performance

MET stock traded down $2.34 during trading on Friday, hitting $97.61. 1,779,470 shares of the company’s stock traded hands, compared to its average volume of 3,806,027. MetLife has a 52 week low of $67.33 and a 52 week high of $100.93. The stock has a market capitalization of $62.81 billion, a price-to-earnings ratio of 18.70, a P/E/G ratio of 0.74 and a beta of 0.78. The business has a fifty day simple moving average of $89.80 and a 200 day simple moving average of $80.70. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.20 and a current ratio of 0.20.

MetLife Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 8th. Investors of record on Tuesday, August 4th will be paid a dividend of $0.5925 per share. The ex-dividend date of this dividend is Tuesday, August 4th. This represents a $2.37 dividend on an annualized basis and a yield of 2.4%. MetLife’s dividend payout ratio is presently 45.93%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. Jefferies Financial Group increased their price objective on shares of MetLife from $97.00 to $103.00 and gave the company a “buy” rating in a report on Friday, July 10th. JPMorgan Chase & Co. upped their target price on shares of MetLife from $96.00 to $106.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 21st. Barclays raised their target price on shares of MetLife from $94.00 to $97.00 and gave the company an “overweight” rating in a research note on Thursday. Piper Sandler boosted their price target on shares of MetLife from $86.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 24th. Finally, Keefe, Bruyette & Woods raised their price objective on MetLife from $98.00 to $105.00 and gave the company an “outperform” rating in a research report on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $100.71.

MetLife declared that its board has approved a stock buyback plan on Wednesday, August 5th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the financial services provider to reacquire up to 4.8% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s leadership believes its shares are undervalued.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Garton & Associates Financial Advisors LLC purchased a new stake in MetLife during the fourth quarter valued at approximately $30,000. Prosperity Bancshares Inc bought a new position in shares of MetLife during the 4th quarter valued at approximately $31,000. Acumen Wealth Advisors LLC purchased a new stake in MetLife during the 4th quarter valued at $33,000. JPL Wealth Management LLC bought a new stake in MetLife in the third quarter worth $33,000. Finally, Measured Wealth Private Client Group LLC purchased a new position in MetLife during the third quarter worth $35,000. Institutional investors own 94.99% of the company’s stock.

Key Stories Impacting MetLife

Here are the key news stories impacting MetLife this week:

• Positive Sentiment: MetLife reported second-quarter adjusted EPS of $2.43, topping the $2.30 analyst consensus and rising from $2.02 a year earlier. Higher investment income, favorable underwriting, and business-volume growth supported earnings. MetLife Tops Q2 Earnings Estimates on Strong Investment Income
• Positive Sentiment: The board authorized a new $3 billion share-repurchase program, in addition to about $400 million remaining under the prior authorization. The plan could cover up to approximately 4.8% of outstanding shares, signaling management’s confidence in capital generation and potentially supporting per-share earnings. MetLife Announces New $3 Billion Share Repurchase Authorization
• Positive Sentiment: Analyst commentary remains cautiously optimistic, with coverage highlighting MetLife’s organic growth and reaffirming the investment case after the quarterly earnings beat. MetLife’s Q2 Earnings Beat Reaffirms the Buy Case
• Neutral Sentiment: MetLife’s quarterly revenue increased 10.5% year over year to $13.52 billion, while management’s earnings update emphasized ongoing operating momentum and capital strength. MetLife CFO Provides Second Quarter Financial Update
• Neutral Sentiment: MetLife Pet Insurance received a 2026 Pet Innovation Award, providing favorable publicity but likely having limited near-term impact on the parent company’s valuation. MetLife Pet Insurance Wins 2026 Pet Insurance of the Year
• Negative Sentiment: Management faced spread-related headwinds, and the stock’s outperformance and proximity to its 52-week high may be encouraging profit-taking even after the earnings beat. Investors may also be scrutinizing the reported revenue figure, which was below the published consensus estimate.

About MetLife

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.